George “Mike” Robinson is an accomplished healthcare technology executive, medical imaging specialist, and strategic business leader with more than four decades of experience advancing diagnostic medicine, commercial innovation, and healthcare technology integration. Throughout his distinguished career, he has combined deep technical expertise with entrepreneurial vision, sales leadership, and an unwavering commitment to improving patient outcomes. His professional journey spans medical imaging, magnetic resonance imaging (MRI), computed tomography (CT), clinical research, healthcare information technology, and emerging applications of artificial intelligence in disease diagnosis. With a unique ability to connect scientific advancement with practical business strategies, Mike brings a multidimensional perspective to organizations seeking sustainable growth, technological transformation, and meaningful healthcare innovation.
Mike began building his professional foundation at Picker International, where he served as an Account Executive from 1983 to 1999. During this formative chapter, he developed a comprehensive understanding of diagnostic imaging technologies, capital equipment sales, healthcare provider relationships, and the importance of customer-centered business development. The company’s philosophy of prioritizing customer success profoundly influenced his leadership approach and professional values. Rather than viewing commercial relationships as individual transactions, Mike embraced the principle that enduring business success emerges from trust, integrity, and a genuine commitment to helping customers achieve their objectives. These principles became defining characteristics of his career, shaping his approach to leadership, collaboration, and strategic decision-making.
Building on this foundation, Mike joined GE Healthcare in 2000 as an MR Sales Specialist, where he made significant contributions to regional market development and commercial growth. During his tenure, he helped expand MRI sales in his region from approximately $16 million to $52 million over five years, demonstrating his ability to translate technical knowledge into measurable business results. Beyond revenue generation, he distinguished himself through sales force development, customer education, and strategic account management. His leadership emphasized understanding the operational and clinical challenges facing healthcare providers and developing solutions that addressed those challenges while improving patient access to advanced diagnostic technologies. His commitment to mentoring colleagues and cultivating high-performing sales professionals reinforced his belief that organizational success is strengthened when knowledge, opportunity, and accountability are shared.
In 2007, Mike expanded his leadership responsibilities as Director of Sales and Marketing at Diagnostic Center for Disease in Sarasota, Florida. The organization was established as a dedicated 3T MRI diagnostic center focused on prostate cancer and related diseases. In this role, he contributed to marketing, business development, and the advancement of specialized diagnostic applications designed to improve disease assessment and clinical decision-making. The center’s research relationships included GE Healthcare, Confirma, and academic institutions, providing opportunities to explore the intersection of advanced imaging, clinical research, and patient-centered innovation. This experience deepened Mike’s conviction that medical technologies achieve their greatest value when they are integrated into practical clinical protocols that improve diagnostic accuracy, reduce unnecessary interventions, and support more informed treatment decisions.
Mike subsequently joined Toshiba America Medical Systems as MR Modality Manager for the Northwest region, serving from 2008 to 2010. His responsibilities centered on MRI market development, customer engagement, and the strategic positioning of advanced imaging solutions within competitive healthcare environments. He championed a consultative approach to commercial growth, emphasizing that manufacturers could differentiate themselves not simply through technological specifications but by helping healthcare organizations improve clinical performance and strengthen their businesses. His philosophy focused on connecting imaging capabilities with referring physicians, diagnostic workflows, and patient outcomes. This approach reflected his broader understanding that sustainable healthcare innovation requires alignment among technology, clinical practice, operational efficiency, and economic value.
In 2010, Mike assumed the role of President of Resonant Directive, Inc., where he further developed his entrepreneurial leadership and strategic perspective on diagnostic imaging utilization. Recognizing that MRI technology possessed substantial untapped clinical potential, he explored opportunities to expand its application beyond conventional examinations and integrate advanced imaging into broader diagnostic and treatment pathways. His work included the development and introduction of a prostate MRI protocol into clinical practice, with an emphasis on improving risk assessment and reducing unnecessary treatment. Through this initiative, Mike demonstrated his ability to identify gaps between technological capability and clinical adoption, then pursue practical solutions that could create value for healthcare providers and patients alike. His leadership reflected a forward-looking philosophy: meaningful innovation is not defined solely by developing new technologies, but by ensuring that existing and emerging capabilities are used more effectively.
Since 2014, Mike has served as a Partner at Signal Physiology, Inc., an organization focused on developing a systems-based approach to understanding cell signaling, disease behavior, and the complex biological mechanisms underlying chronic illnesses, including cancer. His involvement reflects a continued evolution from medical imaging commercialization toward the integration of diagnostics, genetics, disease research, and advanced analytical methodologies. Signal Physiology’s work seeks to connect emerging scientific discoveries with established diagnostic technologies to support more precise assessments of disease characteristics, progression, and treatment response. Through this work, Mike has broadened his perspective on the relationships among molecular biology, medical imaging, clinical information, and the potential for more personalized approaches to healthcare.
A defining element of Mike’s professional expertise is his ability to recognize the value of information across traditionally separate disciplines. His knowledge encompasses MRI, CT, ultrasound, vascular imaging, cardiac imaging, radiology, picture archiving and communication systems (PACS), Digital Imaging and Communications in Medicine (DICOM), electronic health records (EHR), and healthcare information technology. He understands the importance of integrating these technologies into cohesive clinical environments where information can be accessed, interpreted, and applied effectively. His interests also extend to artificial intelligence, data analytics, and emerging diagnostic applications that may improve the speed, precision, and consistency of healthcare decision-making. By combining practical experience with an ongoing interest in scientific discovery, Mike offers a perspective that connects technical implementation with organizational strategy and long-term clinical value.
Mike’s commitment to research and continuous learning is another distinguishing aspect of his professional identity. He has assembled an extensive research library encompassing more than 20,000 resources related to disease diagnosis, cancer, genetics, and associated scientific disciplines. This body of knowledge reflects his sustained curiosity about the biological processes that influence human health and the technologies capable of improving disease identification and management. Rather than examining developments in isolation, he approaches research through a systems-oriented lens, seeking connections among scientific findings, diagnostic capabilities, clinical workflows, and emerging technologies. This analytical mindset enables him to evaluate complex challenges from multiple perspectives and consider how new discoveries may influence healthcare delivery, commercial opportunities, and future industry direction.
Beyond his technical and scientific contributions, Mike brings extensive experience in commercial leadership, strategic market development, and organizational growth. His background includes capital equipment sales, sales team training, customer relationship management, competitive positioning, technology adoption, and the implementation of advanced diagnostic solutions. He has demonstrated an ability to communicate sophisticated medical concepts to diverse audiences, including healthcare executives, clinicians, commercial teams, and technology stakeholders. His leadership philosophy emphasizes clarity, preparation, collaboration, and the development of long-term relationships. By balancing technical credibility with commercial practicality, he has consistently worked to bridge the gap between innovation and successful market adoption.
Mike’s professional experience also includes international customer relationships and cross-cultural business engagement. His exposure to diverse markets and professional communities has strengthened his appreciation for the different economic, operational, and cultural factors influencing healthcare delivery. He remains open to opportunities involving international collaboration and travel, particularly throughout Latin America, Europe, and Canada. This global perspective complements his interest in the broader forces shaping healthcare, including geopolitical developments, financial conditions, technological change, and evolving expectations surrounding patient care. He recognizes that successful organizations must understand not only their immediate competitive environment but also the external forces that can reshape industries and influence long-term strategic decisions.
His leadership experience extends beyond the corporate and healthcare sectors into community governance, having served as President of two homeowners associations for approximately five years each. These prestigious residential communities included one development comprising 250 homes with an average value of $1.2 million and another featuring 110 residences averaging $2.2 million, situated on a renowned golf course that hosts PGA tournaments. In these roles, Mike was responsible for overseeing community operations, financial stewardship, stakeholder relations, and strategic decision making. He successfully navigated complex and often emotionally charged issues, facilitating resolutions that satisfied all parties while maintaining strong, stable financial positions within both communities. These experiences strengthened his ability to balance competing interests, exercise sound judgment, and lead with transparency, fairness, and accountability, reinforcing the governance principles and leadership qualities he brings to corporate board service.
As he pursues opportunities to serve on corporate boards and advisory committees, Mike is particularly interested in organizations operating within medical imaging, diagnostic technology, healthcare information systems, artificial intelligence, clinical innovation, and related sectors. He is open to companies of varying sizes and stages of development, placing greater emphasis on organizational mission, leadership integrity, and the potential to create meaningful value than on employee headcount or revenue alone. His interests align especially well with enterprises navigating technological transformation, commercial expansion, clinical adoption challenges, or the integration of advanced analytics into healthcare operations. He brings the perspective of an executive who has experienced the healthcare technology landscape from the front lines of sales and customer engagement through senior leadership, entrepreneurial development, and scientific exploration.
Mike’s motivation for board service is rooted in his belief that artificial intelligence and rapid technological advancement are compelling organizations to reassess their capabilities, assumptions, and long-term direction. Having spent decades observing the evolution of medical technology, he recognizes the importance of distinguishing genuine innovation from developments that may not deliver lasting clinical or commercial value. His approach emphasizes identifying patterns, evaluating risks, anticipating potential outcomes, and understanding the relationship between technological progress and the larger economic and geopolitical environment. He believes effective leadership requires the ability to look beyond immediate performance indicators and ask fundamental questions about an organization’s mission, strategic direction, and capacity to remain relevant in a changing world.
Throughout his career, Mike has demonstrated that leadership is most effective when guided by purpose, informed by evidence, and grounded in strong professional relationships. His accomplishments reflect a rare combination of medical technology expertise, business development experience, scientific curiosity, and strategic thinking. Whether helping expand a multimillion-dollar imaging business, advancing specialized diagnostic applications, mentoring sales professionals, or exploring the future of precision medicine, he has remained focused on connecting innovation with practical outcomes. As a prospective board member and strategic advisor, George “Mike” Robinson offers organizations an experienced and thoughtful voice capable of contributing to technology strategy, market development, risk evaluation, and long-term growth. His professional legacy is defined by a commitment to better information, better decisions, stronger organizations, and ultimately, better healthcare.
Character:
Mike exemplifies integrity, accountability, and a relationship-centered approach to leadership, consistently emphasizing customer success, professional trust, and the importance of delivering meaningful value. His commitment to responsible governance, collaborative decision-making, and mission-driven organizations reflects a leadership philosophy grounded in service and long-term stewardship.
Knowledge:
With more than four decades of experience in medical imaging, healthcare technology, clinical research, and commercial development, Mike possesses extensive knowledge of the scientific, technical, and operational factors influencing modern healthcare. His understanding of MRI, CT, diagnostic information systems, artificial intelligence, genetics, and disease assessment enables him to connect established industry expertise with emerging opportunities for innovation.
Strategic:
Mike combines analytical thinking with commercial experience to identify market opportunities, evaluate technological developments, and anticipate challenges that may affect organizational performance. His ability to recognize patterns across healthcare, finance, technology, and broader market conditions positions him to contribute informed perspectives to strategic planning, innovation oversight, and sustainable business growth.
Communication:
A confident communicator and experienced mentor who can translate complex technical and scientific concepts into clear, actionable insights for executives, clinicians, commercial professionals, and other stakeholders. His collaborative leadership style, international business exposure, and commitment to building lasting professional relationships support productive dialogue, effective knowledge sharing, and thoughtful boardroom engagement.
